Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Acne Clinical Trials

A listing of Acne medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (60) clinical trials

Let's face acne together! If you or your child has moderate to severe acne, we invite you to join our investigational drug study of a topical treatment foam. Eligibility Criteria: -Adults or children at least 9 years of age or older -You must have at least 20 red, irritated pimples ...

Let's face acne together! If you or your child has moderate to severe acne, we invite you to join our investigational drug study of a topical treatment foam. Eligibility Criteria: -Adults or children at least 9 years of age or older -You must have at least 20 red, irritated pimples ...

Phase

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

Rosacea is a common inflammatory skin disease affecting up to 10% of adults. Despite this, the etiology of rosacea is unclear, although there may be a genetic predisposition (Chang et al., 2015). Currently, there is no cure. Rosacea can lead to scarring, itching, burning, and is associated with anxiety and ...

Phase

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

This study evaluates the effect of hypertonic saline 23.4% injection in fistulas or sinus tracts in adult patients with hidradenitis suppurativa.

Phase

The Use of Oracea and Epiduo Forte in Severe Acne Patients

This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and weeks 4,8, and 12. All subjects will receive Oracea once daily (QD) and Epiduo Forte at Baseline. WE will evaluate Investigator Global Assessment (IGA), total lesion count, adverse events and concomitant ...

Phase

Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa

Secukinumab is an antibody that inhibits Interleukin-17A, and IL-17 promotes neutrophil activities. Neutrophils are found in large numbers in HS. The expression of the inflammatory cytokines IL-17, IL-1, and TNF- were enhanced in lesional skin of HS patients. Prior studies have demonstrated improvement in HS with biologic medications such as ...

Phase N/A

Studying the Skin Microbiome and the Potential of a Topical Probiotic Cream for Patients With Acne

Probiotics are live micro-organisms which when administered in adequate amounts can exert a health benefit on the host. This health-promoting effects have been extensively studied in the gastrointestinal niche but it becomes more and more clear that other niches are also interesting for the potential of probiotics. Recent breakthroughs in ...

Phase N/A

Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide

The study team plans to enroll a total of 40 subjects with self-reported perimenstrual acne. Eligible women will be over the age of 18 and not on any current therapy. The patients will first arrive for a screening visit, where they will be given questionnaires on acne quality of life ...

Phase

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

To evaluate the efficacy of once-daily application of 1% and 3% HY01 Topical Gel, as assessed by the change in inflammatory lesion count from baseline over the 12-week treatment period in patients with moderate-to-severe papulopustular rosacea.

Phase

Evaluation of the Cutera Enlighten Laser With Micro-Lens Array (MLA) Handpiece Attachment

This is an open-label, prospective, multicenter, pivotal study in approximately 15 male or female subjects, age 18 to 65 years who desire laser treatment for the improvement of moderate to severe acne scars. Subjects will receive up to 6 laser treatments, spaced 6 weeks ( 2 weeks) apart with the ...

Phase N/A